Harrow, Inc. Debt Instrument, Unamortized Discount (Premium), Net
Harrow, Inc. (HROW) had Debt Instrument, Unamortized Discount (Premium), Net of $7.62 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Debt › Debt Instrument, Unamortized Discount (Premium), Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet · last filed 2026-08-10
- 2026-06-30: Debt Instrument, Unamortized Discount (Premium), Net $7.62M.
- 2026-03-31: Debt Instrument, Unamortized Discount (Premium), Net -$7.91M.
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium), Net $6.82M; Debt Instrument, Unamortized Discount (Premium), Net as first filed -$6.82M.
- 2025-09-30: Debt Instrument, Unamortized Discount (Premium), Net -$7.13M.
| Period end | Debt Instrument, Unamortized Discount (Premium), Net | Debt Instrument, Unamortized Discount (Premium), Net as first filed |
|---|---|---|
| 2026-06-30 | $7.62M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | -$7.91M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $6.82M 10-Q · filed 2026-08-10 | -$6.82M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$7.13M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$4.41M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | -$5.70M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$6.97M 10-K · filed 2026-03-02 | |
| 2024-09-30 | -$6.69M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$7.73M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | -$8.60M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$9.58M 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$10.56M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$10.54M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$11.40M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$5.83M 10-K · filed 2024-03-19 | |
| 2022-09-30 | -$2.76M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$2.96M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$3.15M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | -$3.35M 10-K · filed 2022-03-10 | |
| 2016-03-31 | $604.00K 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |